These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1961306)

  • 1. The value of calcium carbonate in treating acidosis, phosphate retention, and hypocalcemia.
    Makoff R
    Nephrol News Issues; 1991 Jul; 5(7):16, 18-9, 32. PubMed ID: 1961306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteodystrophies of chronic uremia].
    Meyrier A; Verger D; Richet G
    Schweiz Rundsch Med Prax; 1971 Dec; 60(50):1667-70. PubMed ID: 5140324
    [No Abstract]   [Full Text] [Related]  

  • 3. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
    Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis].
    Tahara H; Tsujimoto Y; Shouji T; Inaba M; Tabata T; Nishizawa Y
    Clin Calcium; 2005 Sep; 15 Suppl 1():173-9. PubMed ID: 16279021
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium carbonate treatment of uremic acidosis.
    Berlyne GM
    Isr J Med Sci; 1971 Nov; 7(11):1235-9. PubMed ID: 5159605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Hypocalcemia in renal insufficiency].
    Renner E
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2623. PubMed ID: 4373222
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic calcium carbonate therapy in uremia.
    Makoff DL; Gordon A; Franklin SS; Gerstein AR; Maxwell MH
    Arch Intern Med; 1969 Jan; 123(1):15-21. PubMed ID: 5248746
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium-based phosphate binders are appropriate in chronic renal failure.
    Friedman EA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):704-9. PubMed ID: 17699276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.
    Hannula PM; Pörsti IH; Saha HH; Kalliovalkama J; Jolma PM; Kööbi P; Olander RM; Antonen JA
    Clin Nephrol; 2004 Jun; 61(6):406-12. PubMed ID: 15224804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical disorders of calcium and phosphate.
    Agus ZS; Goldfarb S
    Med Clin North Am; 1981 Mar; 65(2):385-99. PubMed ID: 6453262
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients.
    Iwasaki Y; Takami H; Tani M; Yamaguchi Y; Goto H; Goto Y; Goto Y; Shigematsu T
    Ther Apher Dial; 2005 Aug; 9(4):347-51. PubMed ID: 16076380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium carbonate in hyperphosphatemia.
    Mayo M; Middleton RK
    DICP; 1991 Sep; 25(9):945-7. PubMed ID: 1949973
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
    Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM
    Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic calcifications after parathyroidectomy in a dialysis patient.
    Mattu M; Yarlagadda SG
    Nephrology (Carlton); 2013 Sep; 18(9):646-7. PubMed ID: 23980815
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM; Farmer B; Smits G; Chonchol M
    J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iatrogenic hypercalcemia in chronic renal failure].
    Snarska J; Sulima-Gillow A; Młotkowska E; Chocianowicz H
    Pol Tyg Lek; 1980 Nov; 35(46):1761-4. PubMed ID: 7243638
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
    Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
    Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
    Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Osteopathies and calcium metabolism].
    Ritz E
    MMW Munch Med Wochenschr; 1974 May; 116(22):1104. PubMed ID: 4211602
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphate binders and metabolic acidosis.
    Marano M
    Hemodial Int; 2015 Apr; 19(2):352. PubMed ID: 25690068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.